Overview

Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines

Status:
Unknown status

Trial end date:
2007-01-01

Target enrollment:

Participant gender:

Summary

This project aims to test the hypothesis that oral consumption of a specific strain of the probiotic bacterium Lactobacillus fermentum (trademarked PCC®) is able to significantly enhance the immune response to a vaccine for influenza.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Probiomics Ltd

Treatments:

Vaccines